Rosen Law Firm Files Class Action Suit Against Hims & Hers Health, Inc

Rosen Law Firm, a global investor rights law firm, has announced a class action lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS) on behalf of investors who purchased securities between August 4, 2025, and July 29, 2026, inclusive. The lawsuit alleges that the company engaged in misleading practices, including sharing consumer health information with third-party advertising platforms and charging consumers for prescriptions almost immediately after submitting intake forms, contrary to their stated intentions.

According to the lawsuit, these practices subjected Hims to regulatory scrutiny, potentially leading to fees and penalties. The firm claims that the company's positive statements about its business, operations, and prospects were materially misleading and lacked a reasonable basis. The case aims to recover damages for investors who were affected by these practices.

Rosen Law Firm is urging investors who purchased Hims securities during the class period to act quickly. To join the lawsuit, investors can visit the firm's website at Rosen Law Firm or contact the firm directly. The deadline for investors to seek appointment as lead plaintiff is November 2, 2026.

The lawsuit emphasizes that if investors wish to serve as lead plaintiff, they must file a motion with the court by the stated deadline. The firm represents investors globally in securities class actions and shareholder derivative litigation, having achieved significant settlements in the past. Rosen Law Firm was ranked number one by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has secured billions of dollars for investors.

Hims & Hers Health, Inc. is a healthcare-focused company that provides digital health services and products. The allegations in the lawsuit are significant and could have substantial implications for the company and its investors. The case highlights concerns over data privacy, transparency, and regulatory compliance in the healthcare industry.

As the deadline approaches, investors are encouraged to take action to protect their interests. By joining the lawsuit, they may be eligible for compensation without incurring any out-of-pocket costs. The Rosen Law Firm's experience in handling complex securities cases ensures that investors have a dedicated team to advocate on their behalf.